Amyloid-beta in CSF: meta-analysis of accuracy in diagnosis


A meta-analysis has concluded that amyloid-beta1-42 in CSF is useful for discriminating Alzheimer’s disease from controls (Rosa et al. J Alzheimers Dis 2014; epublished January 21, 2014).

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page